Merck (MRK) reported Q2 FY 2021 earnings of $1.31 per share (versus $1.02 per share in Q2 FY 2020), missing analysts’ consensus estimate of $1.35 per share.
The company’s quarterly revenues amounted to $11.402 bln (+21.9% y/y), beating analysts’ consensus estimate of $11.203 bln.
MRK fell to $78.07 (-0.33%) in pre-market trading.